Faeth Therapeutics, Inc.

NASDAQ:FTH

Biotechnology

Healthcare
$8.72 +5.01%

+$1.43 today

Market cap
$224.79M
Beta
-0.31
P/E (TTM)
-0.2
EPS (TTM)
-$34.65
52W Low $7.21High $37.90

Volume 0.33M

Average 0.12M

Price history

Faeth Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+2.11%

Period high

$40.05

Period low

$7.89

Latest

$8.72

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
8-KNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
S-8Nov 3, 2026Nov 3, 2026
8-KNov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
10-QNov 3, 2026Nov 3, 2026
8-KOct 27, 2026Oct 27, 2026
4Oct 27, 2026Oct 27, 2026
3Oct 27, 2026Oct 27, 2026
8-KSep 17, 2026Sep 17, 2026
4Sep 15, 2026Sep 15, 2026
3Sep 15, 2026Sep 15, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026

Competitors

Who does Faeth Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about FTH's filings, answered from its disclosures.

What is the latest FTH filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does FTH have?

Intrinsic Alpha currently shows 20 recent filings for FTH.